Lung Cancer COAST: Durvalumab + Oleclumab/Monalizumab Therapy in Patients with Unresectable NSCLC Apr 17, 2023
Lung Cancer ATEZO-BRAIN: Atezolizumab Plus Carboplatin & Pemetrexed in NSCLC with untreated Brain Metastases Apr 17, 2023
Lung Cancer Efficacy and Safety of Pemigatinib in Pan-Cancer have an Acceptable Safety Profile: FIGHT-101 Apr 17, 2023
Lung Cancer Neoadjuvant Sintilimab Plus Chemotherapy: Two Cycles vs. Three for Resectable NSCLC Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Comparing Perioperative Nivolumab vs Observation in RCC Patients Undergoing Nephrectomy: PROSPER Phase 3 Study Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Phase 2 LITESPARK-004: Belzutifan, a HIF-2α Inhibitor, for VHL Disease-Associated Neoplasms Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Telaglenastat Plus Cabozantinib vs. Placebo Plus Cabozantinib in Advanced RCC Patients:CANTATA Phase 2 Trial Apr 17, 2023
